| 发明名称 |
Treatment of disorders secondary to organic impairments |
| 摘要 |
A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
|
| 申请公布号 |
US2002137798(A1) |
申请公布日期 |
2002.09.26 |
| 申请号 |
US20020092144 |
申请日期 |
2002.03.06 |
| 申请人 |
MUELLER PETER STERLING |
发明人 |
MUELLER PETER STERLING |
| 分类号 |
A61K45/00;A61K31/00;A61K31/135;A61K31/137;A61P3/10;A61P5/00;A61P21/02;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/14;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/36;A61P27/02;A61P31/12;A61P35/00;A61P43/00;(IPC1-7):A61K31/137 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
